U.S. Markets closed
  • S&P Futures

    3,654.00
    +30.75 (+0.85%)
     
  • Dow Futures

    29,868.00
    +239.00 (+0.81%)
     
  • Nasdaq Futures

    12,381.00
    +104.00 (+0.85%)
     
  • Russell 2000 Futures

    1,841.40
    +21.30 (+1.17%)
     
  • Crude Oil

    44.91
    -0.43 (-0.95%)
     
  • Gold

    1,786.30
    +5.40 (+0.30%)
     
  • Silver

    22.93
    +0.34 (+1.51%)
     
  • EUR/USD

    1.1962
    +0.0027 (+0.2273%)
     
  • 10-Yr Bond

    0.8440
    +0.0020 (+0.24%)
     
  • Vix

    20.57
    -0.27 (-1.30%)
     
  • GBP/USD

    1.3356
    +0.0024 (+0.1830%)
     
  • USD/JPY

    104.3500
    +0.0260 (+0.0249%)
     
  • BTC-USD

    19,596.87
    +86.99 (+0.45%)
     
  • CMC Crypto 200

    384.57
    +19.97 (+5.48%)
     
  • FTSE 100

    6,266.19
    -101.39 (-1.59%)
     
  • Nikkei 225

    26,824.46
    +390.84 (+1.48%)
     

Amphastar Pharmaceuticals Inc (AMPH) Files 10-K for the Fiscal Year Ended on December 31, 2018

GuruFocus.com

- By insider

Amphastar Pharmaceuticals Inc (AMPH) files its latest 10-K with SEC for the fiscal year ended on December 31, 2018. Amphastar Pharmaceuticals Inc is a specialty pharmaceutical company engaged in developing, manufacturing, marketing and selling generic and proprietary injectable & inhalation products. Its products are used in hospitals or urgent care clinical settings. Amphastar Pharmaceuticals Inc has a market cap of $955.938 million; its shares were traded at around $20.50 with and P/S ratio of 3.68.


For the last quarter Amphastar Pharmaceuticals Inc reported a revenue of $89.7 million, compared with the revenue of $60.40 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $294.7 million, an increase of 22.7% from last year. For the last five years Amphastar Pharmaceuticals Inc had an average revenue growth rate of 4.9% a year.

The reported loss per diluted share was 12 cents for the year, compared with the earnings per share of $0.22 in the previous year. The Amphastar Pharmaceuticals Inc had an operating margin of -2.93%, compared with the operating margin of -1.47% a year before. The 10-year historical median operating margin of Amphastar Pharmaceuticals Inc is -1.47%. The profitability rank of the company is 3 (out of 10).

At the end of the fiscal year, Amphastar Pharmaceuticals Inc has the cash and cash equivalents of $86.3 million, compared with $65.6 million in the previous year. The long term debt was $32.0 million, compared with $40.8 million in the previous year. Amphastar Pharmaceuticals Inc has a financial strength rank of 6 (out of 10).

At the current stock price of $20.50, Amphastar Pharmaceuticals Inc is traded at 21.1% premium to its historical median P/S valuation band of $16.93. The P/S ratio of the stock is 3.68, while the historical median P/S ratio is 3.04. The stock gained 1.28% during the past 12 months.

CFO Recent Trades:

  • CFO, SVP & Treasurer William J Peters sold 1,500 shares of AMPH stock on 03/04/2019 at the average price of $25.36. The price of the stock has decreased by 19.16% since.

  • CFO, SVP & Treasurer William J Peters sold 10,016 shares of AMPH stock on 02/15/2019 at the average price of $24.37. The price of the stock has decreased by 15.88% since.

Directors and Officers Recent Trades:

  • President and General Counsel Jason B. Shandell sold 7,500 shares of AMPH stock on 03/01/2019 at the average price of $24.99. The price of the stock has decreased by 17.97% since.

  • EVP, Production Center Rong Zhou sold 3,200 shares of AMPH stock on 03/01/2019 at the average price of $25. The price of the stock has decreased by 18% since.

  • SVP Corp Admin Center Yakob Liawatidewi sold 8,868 shares of AMPH stock on 02/14/2019 at the average price of $23.86. The price of the stock has decreased by 14.08% since.

  • President and General Counsel Jason B. Shandell sold 7,519 shares of AMPH stock on 02/14/2019 at the average price of $23.99. The price of the stock has decreased by 14.55% since.

For the complete 20-year historical financial data of AMPH, click here.

This article first appeared on GuruFocus.